JPS5843797A - Enzyme electrode - Google Patents
Enzyme electrodeInfo
- Publication number
- JPS5843797A JPS5843797A JP56140324A JP14032481A JPS5843797A JP S5843797 A JPS5843797 A JP S5843797A JP 56140324 A JP56140324 A JP 56140324A JP 14032481 A JP14032481 A JP 14032481A JP S5843797 A JPS5843797 A JP S5843797A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- membrane
- electrode
- immobilized
- immobilized enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】 本発明は固定化酵素を備えたII素電極に関する。[Detailed description of the invention] The present invention relates to a II elementary electrode equipped with an immobilized enzyme.
固定化酵素膜を備え九酵素電極は、酵素がその基質に対
してのみ選択的に反応を行う機能を利用し九もので、優
れた選択性を有していることと酵素は触媒的作用をなす
ので長時間繰り返し使用できるので高価な酵素でも安価
に分析が行えることから将来の発展が注目されて匹る@
特に、生化学分析、臨床化学分析等の分野で重畳な役割
をはたし得るものである。例えばウリカーゼを利用した
場合、痛風診断における重畳な役割をはたす尿酸の分析
ができ、糖尿病診断・治療に極めて重畳なグルコースの
分析にはグルコースオキシダーゼが利用できる等、酵素
を利用した酵素電極では、短時間にしかも容易に分析が
行えるので早期診断、ベッドサイドでの治療時等に有用
である。The enzyme electrode, which is equipped with an immobilized enzyme membrane, utilizes the ability of enzymes to selectively react only with respect to their substrates. Because it is an eggplant, it can be used repeatedly for a long time, and even expensive enzymes can be analyzed at low cost, so its future development is attracting attention.
In particular, it can play an overlapping role in fields such as biochemical analysis and clinical chemical analysis. For example, when using uricase, it is possible to analyze uric acid, which plays an overlapping role in gout diagnosis, and glucose oxidase can be used to analyze glucose, which plays an extremely important role in diabetes diagnosis and treatment. Since analysis can be performed quickly and easily, it is useful for early diagnosis, bedside treatment, etc.
しかし従来は、直接固定化酵素膜が被検液体である血液
、尿等に接触するので、これらに含まれるタンパク質、
血球、#素等の付着による性能低下中タンパク質分解酵
素等による酵素の分解等のため、さらに固定化された酵
素が安定性に欠くため酵素電極の感度応答性の低下が著
しくひんばんに洗浄を繰り返したυ、短期間に固定化酵
素膜を交換しなければならない不、便さがあった。また
。However, in the past, directly immobilized enzyme membranes came into contact with test liquids such as blood and urine, so the proteins contained in these
Due to decomposition of the enzyme by proteolytic enzymes, etc., the sensitivity response of the enzyme electrode is significantly reduced due to the immobilized enzyme lacking stability. There was the inconvenience and inconvenience of repeatedly having to replace the immobilized enzyme membrane within a short period of time. Also.
酵素を固定化する際に蝶、固定化方法によシ異なるが一
般に酵素活性が低下し九〇、lI1票が膜から脱落して
しまい安定性のない固定化酵素膜しか得られなかった。When immobilizing enzymes, the enzyme activity generally decreased, depending on the immobilization method, and lI1 particles fell off the membrane, resulting in an unstable immobilized enzyme membrane.
又、固定化酵素膜の保存は、乾燥状態で又は緩衝液中に
て保存する丸め長期間保存における安定性が必ずしも充
分なものといえず実用的な性能が化酵素層を備えた高感
度で長期間安定な酵素電極を提供することを目的とする
。In addition, the stability of immobilized enzyme membranes during long-term storage, such as storing them in a dry state or in a buffer solution, is not necessarily sufficient, and the practical performance is limited to high-sensitivity membranes equipped with an enzyme layer. The purpose is to provide an enzyme electrode that is stable for a long period of time.
本発明は電気信号取出のための電極と、酵素賦活剤およ
び酵素又は粒状担体に固定化した酵素をゲル親水性物質
に分散せしめ、かつ前記電極表面に設けられた固定化酵
素層と、前記固定化酵素膜表面に設けられた選択透過層
とを具備した酵素電極であシ、さらに選択透過層として
厚さ方向で孔径の不均一な非対称多孔質膜を用いる事に
より一層優れた特性0酵素電極が得られるというもので
ある。The present invention comprises an electrode for extracting an electrical signal, an enzyme activator and an enzyme or an enzyme immobilized on a granular carrier dispersed in a gel hydrophilic substance, and an immobilized enzyme layer provided on the surface of the electrode; This is an enzyme electrode equipped with a permselective layer provided on the surface of the enzyme membrane, and an asymmetric porous membrane with non-uniform pore diameters in the thickness direction is used as the permselective layer, resulting in an enzyme electrode with even better properties. is obtained.
この様な本発明においy、、は固定化酵素膜として酵素
賦活剤および酵素又は粒状担体く固定化した酵素をゲル
親水性物質(分散せしめた固定化酵素を用いる事によ)
酵素活性を高め、高感度とすると共に、さらに酵素の安
定性を高め寿命を著しく改善する事が出来るというもの
である。In the present invention, as an immobilized enzyme membrane, an enzyme activator and an enzyme or an enzyme immobilized on a granular carrier are mixed with a gel hydrophilic substance (by using a dispersed immobilized enzyme).
In addition to increasing the enzyme activity and making it highly sensitive, it also increases the stability of the enzyme and significantly improves its lifespan.
また本発明における固定化酵素膜表面に設けられた選択
透過膜は被検体よの血球や夕・バク質が固定化酵素層に
付着し汚染するのを防ぎ固定化酵素層においての酵素反
応を防害する成分の影響を低減することができる。特に
選択透過膜として厚さ方向で孔径の不均一な非対称多孔
質膜を用い九場合には酵素が固定化されたゲル親水性物
質が非対称の選択透過膜の孔径が大きい側にうめこまれ
るような固定化酵素膜となり、被検体液に接している側
の小さい孔径からは脱落することがなく、長期間、高感
度を維持している定電な酵素電極が得られる。In addition, the selectively permeable membrane provided on the surface of the immobilized enzyme membrane in the present invention prevents blood cells and bacteria from the sample from adhering to and contaminating the immobilized enzyme layer, and prevents enzyme reactions in the immobilized enzyme layer. The influence of harmful components can be reduced. In particular, when an asymmetric porous membrane with non-uniform pore diameters in the thickness direction is used as a selectively permeable membrane, the gel hydrophilic substance on which the enzyme is immobilized is embedded in the side with larger pores of the asymmetric selectively permeable membrane. This results in an immobilized enzyme membrane that does not fall off from the small pore diameter on the side that is in contact with the sample body fluid, resulting in a constant voltage enzyme electrode that maintains high sensitivity for a long period of time.
なお本発明゛における選択透過膜とは、例えばグ・il
ルコース、・尿酸、′昇素、コレステロール等の#素反
応の基質となる化・□番物(主に分子量数十〜千程度)
の1゜
透過に対して実質的な障害とならず、汚染等の主役をは
たす巨大分子(血液中のタンパク質のほとんどが2万以
上のもの)を通さないものであれば適宜選択する事がで
き、セルロース鐸導体、ポリアミド、ポリアクリロニト
リル、ポリスチレ/等溶媒を決める事が好ましい。また
上記選択透過層は、薄い程応答速度が速くなるが実用上
10λ〜数μm程度とする事が好ましい。The selectively permeable membrane in the present invention refers to, for example, chemical compounds (mainly molecules with a molecular weight of several tens to thousands) that are substrates for elementary reactions such as glucose, uric acid, ``elevation,'' and cholesterol.
The material can be selected as appropriate, as long as it does not substantially impede the permeation of 1° and does not allow the passage of large molecules (most of the proteins in the blood are over 20,000), which play a major role in contamination. , cellulose conductor, polyamide, polyacrylonitrile, polystyrene/etc. It is preferable to decide on the solvent. The thinner the selectively permeable layer is, the faster the response speed is, but in practice it is preferably about 10 λ to several μm.
また、必要に応じて用いられる酵素を結合する一担体と
しては、ポリビニールアルコール、多孔性ガラス、PV
A繊fi、スーパーファインファイバー、グラスピース
、ポ、リアノオノマービーズなどが使える。またゲル親
水性物質としては、ポリビニルピロリドン、ポリアクリ
ルアミド鱒導体、ポリビニールアルコール、ポリアクリ
ル酸ナトリウムゲル、ポリエチレンオキシド等合成物質
および天然高分子物質のゼラチンデンプン、コンニャク
粉などが使える。In addition, examples of carriers for binding enzymes that may be used as needed include polyvinyl alcohol, porous glass, PV
You can use A fi, super fine fiber, glass pieces, po, rhino onomer beads, etc. As the gel hydrophilic substance, synthetic substances such as polyvinylpyrrolidone, polyacrylamide trout conductor, polyvinyl alcohol, sodium polyacrylate gel, polyethylene oxide, and natural polymer substances such as gelatin starch and konjac powder can be used.
又、酵素活性を促進又は保護する酵素賦活剤としてはウ
レアーゼなどの8H基をもつ酵素ではシスティン、メル
カプトエタノール、トリプシノーゲンではトリプシンな
どがある◇
酵素活性の阻害作用を除去する物質としては、一般に酵
素活性を阻害する金属イオンを除去するためのEDTA
があシ、ウリカーゼでは混在してぃ篭
るカタラーゼが活性を抑制していると考えられているの
で、カタラーゼの活性を阻害するアジ化ナトリウム(N
aN5 )が使用できる。その他、!II素に結合して
いる補体、金属イオン等を適宜加える事も安定性、寿命
向上の点から効果がある。In addition, enzyme activators that promote or protect enzyme activity include cysteine and mercaptoethanol for enzymes with 8H groups such as urease, and trypsin for trypsinogen. EDTA to remove metal ions that inhibit
It is thought that catalase, which is present in the reeds and uricases, suppresses the activity, so sodium azide (N), which inhibits the activity of catalase, is
aN5) can be used. others,! Appropriate addition of complement, metal ions, etc. bound to element II is also effective in improving stability and longevity.
本発明に用いられる酵素としては、ウレアーゼウリカー
ゼ、トリプシノーゲン、グルコースオキシターゼ、コレ
ステロールオキシターゼ、カタラーゼ、ペルオキシダー
ゼ、クレアチンナーゼ、L−アミノ酸I酸化酵素などそ
の他多くの酵素を適宜選択する事ができ、さらにこれら
の酵素はシア端ヒ法、アずド化法、アルキル化法等の共
有結合反応や多官能性試薬(例えば、グルタアルアルデ
ヒド、ヘキサメチレンジイソシアネート等)を介して化
学結合により上記担体に固定化することができる。As the enzyme used in the present invention, many other enzymes such as urease uricase, trypsinogen, glucose oxidase, cholesterol oxidase, catalase, peroxidase, creatinase, and L-amino acid I oxidase can be selected as appropriate. can be immobilized on the above-mentioned carrier by chemical bonding through a covalent bond reaction such as the sialyte method, adzation method, alkylation method, or a polyfunctional reagent (e.g., glutaraldehyde, hexamethylene diisocyanate, etc.). I can do it.
さらに本発明に用いられる電極としては、酸素電極、過
酸化水素電極、炭酸ガス電極、アンモニウムガス電極、
アンモニウムイオン電極、水素イオン電極、カチオン電
極、電導度電極等を用いることができる。Furthermore, the electrodes used in the present invention include oxygen electrodes, hydrogen peroxide electrodes, carbon dioxide electrodes, ammonium gas electrodes,
Ammonium ion electrodes, hydrogen ion electrodes, cation electrodes, conductivity electrodes, etc. can be used.
・以下本発明を実施例を用いて詳細に説明する〇実施例
1
カルボキシル基を有する粒子(平均ff12μm) 3
gを塩酸で弱酸性KpH調整したイオン交換水25m1
、中に加え、続いて1.8−ジアンノー4−アミツメチ
ルオクタンを1.5m7加見て攪拌状11に保つ。粒子
が液中に分散した後、ペプチド合成用水溶性カルyit
ジイミド鱒導体(1−シクロへキシル−3−く2−モ
ルフォリノエチル〉カルボシイオド−メソ−P−)ルエ
ンスルフォネート;]E)X化成)o、s gを加えて
室温で3時間反応する。続いて。・Hereinafter, the present invention will be explained in detail using examples〇Example 1 Particles having carboxyl groups (average ff 12 μm) 3
25ml of ion-exchanged water whose pH was adjusted to slightly acidic with hydrochloric acid
, and then 1.5 m7 of 1,8-dianno-4-aminomethyloctane was added and kept at a stirring state of 11 ml. After the particles are dispersed in the liquid, a water-soluble calcium compound for peptide synthesis is added.
Diimide trout conductor (1-cyclohexyl-3-2-morpholinoethylcarbosiodo-meso-P-)luenesulfonate;]E) . continue.
この粒子を5sグルタルアルデヒ、ド溶液(pH7,6
)に接触させて酵素固定化用の粒状担体とした0さ、、
に2゜ヨウ、。ついアー贅□1シイ88ヶオヵル社)溶
液に加えウレアーゼを固定し所定の固定化酵素を得た。The particles were mixed with 5s glutaraldehyde solution (pH 7, 6).
) to form a granular carrier for enzyme immobilization.
2 degrees. Then, urease was immobilized by adding to the solution (Ocal Co., Ltd.) to obtain a predetermined immobilized enzyme.
なお酵素固定化用の粒状担体への酵素固定化量はウレア
ーゼ溶液の吸光度の減少よシ算出したところ約5mg/
g wet粒子の固定化ウレアーゼ粒子が得られた。The amount of enzyme immobilized on the granular carrier for enzyme immobilization was calculated based on the decrease in absorbance of the urease solution, and was approximately 5 mg/
Immobilized urease particles of g wet particles were obtained.
一方、ゲル親水性物としてケン化度98.5%、重合度
500のポリビニールアルコールt ”lnM pH7
,5のリン酸緩衝液中に加重量慢になるように調製し、
50’0に加熱した後急冷し脱気した。この溶液にβ−
メルカプトエタノール1mMを添加して、さらに先のウ
レアーゼを固定した固定化酵素を加え攪拌し、5℃にて
保存した。On the other hand, polyvinyl alcohol t''lnM pH 7 with a degree of saponification of 98.5% and a degree of polymerization of 500 is used as a gel hydrophilic material.
, 5 in phosphate buffer,
After heating to 50'0, it was rapidly cooled and degassed. This solution contains β-
1 mM of mercaptoethanol was added, and the immobilized enzyme with the urease immobilized above was added, stirred, and stored at 5°C.
使用の際に第1図に示すように非対称多孔質膜からなる
選択透過膜(1)を5重量−のホウ酸溶液に浸漬して5
分後ひきあけ(第1図cA))非対称の選択透過膜の孔
径の大きい側(IJI)に前記固定化酵素の分散した溶
液をぬ>(第1図(B))組成物中のポリビニールアル
コールをゲル化する。In use, as shown in Figure 1, a selectively permeable membrane (1) consisting of an asymmetric porous membrane is immersed in a 5% by weight boric acid solution.
After opening (Fig. 1 cA)) the solution in which the immobilized enzyme is dispersed is poured onto the larger pore size side (IJI) of the asymmetric permselective membrane (Fig. 1 (B)). Gel the alcohol.
このようにしてで髄た固定化ウレアーゼ粒子を:。The immobilized urease particles were thus:
分散せしめ九固定化酵素膜(2)が設けられた。選択透
過膜(1)を0.5重量係のホウ酸溶液で洗浄しく第1
図(0>水溶性物質を除き非対称多孔質膜からなるj択
透過1[)内11(la)K接してアンモニft A
lj x電極(オリオン社95−1o)を設け、又外側
(IJI)に被検液が接する如くして酵素電極を作成し
九〇このようにした得られた酵素電極(第2図)を用い
、0.1Mリン酸緩衝液pH7,5をml1分の速度で
連続的にポンプにょシ送シながら酵素電極の入口で緩衝
液流中に尿素の試料(資)μノをマイクロシリジで注入
する。なお第2図中(1)は固定化酵素膜、(2)は選
択透過膜、(3)はアンそニウム電極筒体、(4)はア
ンモニウムガス透過膜、(5)はスペーサー、(6)は
電極内部液をそれぞれ示す。A dispersed and immobilized enzyme membrane (2) was provided. First, wash the selectively permeable membrane (1) with a 0.5 weight percent boric acid solution.
Diagram (0>J consisting of an asymmetric porous membrane excluding water-soluble substances) Inside 11 (la) K in contact with ammonia ft A
An enzyme electrode was prepared by installing a lj x electrode (Orion Co., Ltd. 95-1o) and having the outside (IJI) in contact with the test liquid.90 Using the enzyme electrode thus obtained (Fig. 2) While continuously pumping 0.1M phosphate buffer pH 7.5 at a rate of 1 minute, a sample of urea (μ) was injected into the buffer flow at the inlet of the enzyme electrode using a microsyringe. In Figure 2, (1) is the immobilized enzyme membrane, (2) is the selectively permeable membrane, (3) is the ammonium electrode cylinder, (4) is the ammonium gas permeable membrane, (5) is the spacer, and (6) is the ammonium gas permeable membrane. ) indicates the electrode internal solution, respectively.
尿素は固定化酵素膜内で次式のように分解されるのでア
ンモニウムイオンの生成量を電圧変化で測定することに
より尿素量を測定した。Since urea is decomposed within the immobilized enzyme membrane as shown in the following equation, the amount of urea was measured by measuring the amount of ammonium ions produced by voltage changes.
JR素+ HzO力G上−< 2NH4” + HCO
s−このようにして得た本発明に係る酵素電極を用い人
血清を試料として使用したとき、最初に示し友感度を示
し九まt aoo回以上の繰p返し使用に耐えることが
できた。なお従来方法にょシ得た30gアクリルアシド
モノマーと0.58 g N −Nメチレンビスアクリ
ルアシドを25rnl O0,IM )リス緩衝液pH
7,0でとかした固定化ウレアーゼ膜は400回程度で
使用不可能となった。又、固定化ウレアーゼ粒子の分散
している溶液は5℃で3ケ月以上はウレアーゼ活性の低
下はみられなかった。JR element + HzO force G top - <2NH4" + HCO
When human serum was used as a sample using the enzyme electrode according to the present invention obtained in this manner, it exhibited a high level of friendliness and could withstand repeated use more than 9 times. In addition, 30 g of acryl acid monomer obtained using the conventional method and 0.58 g of N-N methylenebisacrylic acid were mixed in 25 rnl O0, IM) of Lith buffer pH.
The immobilized urease membrane combed with 7.0 became unusable after about 400 cycles. Furthermore, no decrease in urease activity was observed in the solution containing the immobilized urease particles dispersed at 5° C. for 3 months or more.
以上詳述した如く本発明によれば、被検体液の酵素電極
の汚染を防ぎ、高感度で長期間安定な酵素電極ができ、
臨床化学分析の七ンサ一部等に使用していくことが可能
である。As detailed above, according to the present invention, it is possible to prevent contamination of the enzyme electrode with the body fluid to be examined, and to provide a highly sensitive and long-term stable enzyme electrode.
It can be used as a part of clinical chemistry analysis.
第1(50■(B) (0は本発明における固定化酵素
膜の製法工程を示す図、第2図は本発明における酵素電
極の断面図である。
1・・・固定化酵素層、
2・・・選択透過膜(穴径2 a>2 b )、3・・
・アンモニウムガス電極筒体、
4・・・アンモニウムガス透過111..5・・・スペ
ーサー、
6・・・電極内部液
代理人 弁理士 則 近 憲 佑(はか1名)第
1 図
第 2 図1st (50■(B)) (0 is a diagram showing the manufacturing process of the immobilized enzyme membrane in the present invention, and FIG. 2 is a cross-sectional view of the enzyme electrode in the present invention. 1... Immobilized enzyme layer, 2 ... selectively permeable membrane (hole diameter 2 a > 2 b ), 3...
- Ammonium gas electrode cylinder, 4... Ammonium gas permeation 111. .. 5... Spacer, 6... Electrode internal liquid agent Patent attorney Noriyuki Chika (1 person) No.
1 Figure 2
Claims (1)
酵素又は粒状担体に固定化した酵素をゲル属水性物質に
分散せしめ、かつ前記電極表面に設けられ九固定化酵素
Jl、!−、前記固定化#素膜表面に設けられ九選択透
過膜とを具備することを特徴とした酵素電極。 (2、特許請求の範囲第1項において選択透過膜として
厚さ方向で孔径の不均一な伸対称多孔質膜を用いた事を
特徴とする酵素電極。(1) An electrode for extracting an electric signal, an enzyme activator and an enzyme, or an enzyme immobilized on a granular carrier, dispersed in a gel aqueous substance, and nine immobilized enzymes Jl provided on the electrode surface! - an enzyme electrode comprising: a selectively permeable membrane provided on the surface of the immobilized elementary membrane; (2. An enzyme electrode according to claim 1, characterized in that an elongated symmetrical porous membrane with non-uniform pore diameters in the thickness direction is used as the permselective membrane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56140324A JPS5843797A (en) | 1981-09-08 | 1981-09-08 | Enzyme electrode |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56140324A JPS5843797A (en) | 1981-09-08 | 1981-09-08 | Enzyme electrode |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5843797A true JPS5843797A (en) | 1983-03-14 |
Family
ID=15266163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56140324A Pending JPS5843797A (en) | 1981-09-08 | 1981-09-08 | Enzyme electrode |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5843797A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020509373A (en) * | 2017-03-03 | 2020-03-26 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドSiemens Healthcare Diagnostics Inc. | Method for producing biosensor containing nanobeads and use thereof |
-
1981
- 1981-09-08 JP JP56140324A patent/JPS5843797A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020509373A (en) * | 2017-03-03 | 2020-03-26 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドSiemens Healthcare Diagnostics Inc. | Method for producing biosensor containing nanobeads and use thereof |
US11585809B2 (en) | 2017-03-03 | 2023-02-21 | Siemens Healthcare Diagnostics Inc. | Nanobead containing biosensors and methods of production and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dhawan et al. | Recent developments in urea biosensors | |
Broun | [20] Chemically aggregated enzymes | |
CA1039163A (en) | Urea analysis | |
Schneider et al. | Hydrogel matrix for three enzyme entrapment in creatine/creatinine amperometric biosensing | |
GB2034242A (en) | Enzyme-containing membrane for use in electrochemical analysis cell | |
JP2000507457A (en) | Enzyme sensor | |
CA2109896A1 (en) | Method and system for determining bioactive substances | |
JPS6029475B2 (en) | Immobilized enzyme membrane and its manufacturing method | |
Guilbault et al. | Enzyme electrodes for the determination of 1-phenylalanine | |
Mascini et al. | Clinical uses of enzyme electrode probes | |
JPH0363018B2 (en) | ||
Ikariyama et al. | High performance micro-enzyme sensor using platinized microelectrode. | |
US3896008A (en) | Electrochemical potentiometric method for selectively determining alkaline phosphatase content in aqueous fluids | |
Kobos | Potentiometric enzyme methods | |
Guilbault | [2] Enzyme electrode probes | |
JP4248744B2 (en) | Planar biosensor with microstructure, method of using the same, and method of immobilizing biocatalyst | |
SU1034618A3 (en) | Electrochemical transducer for determining concentration of substances in solutions | |
JPS5843797A (en) | Enzyme electrode | |
Hsiue et al. | Urease immobilized polyvinyl alcohol‐g‐butyl acrylate membrane for urea sensor | |
Everse et al. | Immobilized enzymes in biochemical analysis | |
JPS59164953A (en) | Immobilized enzyme film and manufacture thereof | |
JP2528102B2 (en) | Glucose substrate sensitive electrode that diffuses in two directions | |
Hirose et al. | Determination of urea in blood serum with use of immobilized urease and a microwave cavity ammonia monitor | |
JPH08336399A (en) | Detection of arginine and arginine sensor | |
Aizawa et al. | Immobilized mitochondrial electron transport particle for NADH determination |